Daniel Molnar, PhD Boehringer-Ingelheim

Daniel Molnar is a pharmacist by training and received his Ph.D. from the department of Pharmaceutical Technology and Biopharmacy at the Albert-Ludwigs-University of Freiburg (Germany) in 2015. Since beginning of 2016 he works at Boehringer Ingelheim Pharma GmbH & Co. KG first as a research scientist (2016 - 2018) and from February 2018 on as principal scientist/ head of laboratory in the Formulation and Process Development Biologicals Late Stage. Among other duties, he concentrates on lyophilization process robustness and feasibility studies as well as on the scale up from small scale to commercial production.